A long-overdue name change is reshaping how we understand one of the most common hormonal conditions in women.
If you have been living with a diagnosis of PCOS (Polycystic Ovary Syndrome) or you have recently been told you might have it, you may have come across a term that sounds unfamiliar: PMOS. This is not a typo, a new disease, or a different condition altogether. It is the same condition you already know, under a new, far more accurate name.
PMOS stands for Polyendocrine Metabolic Ovarian Syndrome. On May 12, 2026, this rename was officially published in The Lancet by a global consortium of leading endocrinologists, gynaecologists, and patient advocates. The goal was clear: to give this condition a name that finally reflects what it actually is, a complex, whole-body hormonal and metabolic condition, not simply a structural problem with the ovaries.
The prefix “Poly” is retained because the condition involves multiple (“poly”) endocrine glands and systems. “Endocrine” acknowledges the broader hormonal system involvement, including the adrenal glands, pancreas, thyroid, and pituitary. “Metabolic” recognises that insulin resistance and metabolic dysfunction sit at the core of the condition for most women. And “Ovarian Syndrome” keeps the ovarian connection while removing the misleading implication of cysts.
Published in The Lancet by a global consortium on May 12, 2026, and endorsed by the Endocrine Society. The new name reflects that this is a multi-gland, metabolic condition, not a structural ovarian problem. This single renaming has significant implications for how the condition is diagnosed, treated, and understood worldwide.
Language matters enormously in medicine. When a condition is misnamed, it gets misunderstood, misdiagnosed, and mistreated. This is exactly what happened with PCOS for decades.
The “cyst” in PCOS was always a misnomer. The ovarian finding is multiple small follicles, not pathological cysts, creating decades of unnecessary fear and misunderstanding.
The condition affects the pancreas (insulin), adrenal glands (cortisol, DHEA), thyroid, and pituitary, not just the ovaries. “Polyendocrine” finally captures this whole-body reality.
Up to 70% of women with this condition have insulin resistance. The old name gave no hint of this metabolic dimension, leading to years of missed diagnoses and ineffective treatment.
The global consortium behind the rename specifically cited reducing stigma as a key goal. The new name removes the implication of a defective or diseased reproductive organ.
The global consortium that authored the Lancet paper included specialists across endocrinology, reproductive medicine, metabolic health, and patient advocacy from multiple countries. Their consensus was that the old name was not only inaccurate, but actively harmful, delaying diagnosis and narrowing treatment options by focusing attention on the ovaries alone. The Endocrine Society has since endorsed the rename, signalling a major shift in how this condition will be managed going forward.
Take our free hormone assessment quiz to identify where your imbalance may be coming from and what your body actually needs.
Take the Free Hormone Quiz →The symptoms of PMOS are exactly the same as what was previously called PCOS. The condition itself has not changed, only our understanding and labelling of it. If you are experiencing a cluster of these symptoms, it is worth getting a thorough hormonal and metabolic workup.
Your GP may still use the term PCOS as the name transition into mainstream medical practice takes time. If you see PMOS in an article or research paper and your doctor uses PCOS, they are referring to the same condition. The diagnostic criteria have not changed, only the name. Do not let the terminology confusion delay you from getting help.
Conventional medicine has historically treated PCOS (now PMOS) with the oral contraceptive pill and Metformin. While these can manage symptoms in the short term, they do not address the underlying root causes. Using an integrative, root-cause approach, we look at the full picture of why your hormones are out of balance in the first place.
One of the most distressing aspects of a PMOS diagnosis is the concern about fertility. It is important to understand that having PMOS does not mean you cannot get pregnant. Many women with PMOS conceive naturally, and many more do so with targeted support.
The key issue is that irregular or absent ovulation makes timing conception difficult. When you address the root causes, including insulin resistance, inflammation, and stress, ovulation often naturally restores. This is why a root-cause approach to PMOS is so powerful, not just for symptom management, but for long-term reproductive health.
Integrative, root-cause strategies that support fertility in PMOS include restoring regular ovulation through metabolic correction, optimising thyroid function (often overlooked), supporting egg quality through antioxidant-rich nutrition, and addressing nutritional deficiencies commonly seen in PMOS such as magnesium, zinc, vitamin D, and inositol.
Diagnosis has not changed with the name update. The Rotterdam Criteria still apply, requiring two of the following three features to be present:
From a root-cause standpoint, we go beyond these criteria. A full hormonal panel including fasting insulin, HOMA-IR, full thyroid panel, adrenal hormones (DHEA-S, cortisol), and inflammatory markers gives us a far more complete picture of what is driving the condition in each individual woman.
The Ask Dr Olz 21-Day Hormone Reset Programme is designed specifically for women with hormonal imbalances like PMOS. Address insulin resistance, reduce inflammation, and restore your cycle naturally.
Explore the 21-Day Hormone Reset →Beyond terminology, the rename carries real clinical implications. By explicitly acknowledging the morphological nature of the ovarian finding, the new name encourages clinicians to look beyond the ovaries for the true drivers of the condition.
It opens the door for more metabolic testing to become standard of care. It validates what integrative medicine practitioners have argued for years: that this condition is systemic, not localised. And it shifts the conversation away from treating symptoms (irregular periods, acne, unwanted hair) toward treating the whole hormonal and metabolic system.
For women in South Africa, where access to specialist endocrinology can be limited, this is particularly important. A root-cause integrative approach to PMOS empowers you to understand your own body and make targeted, evidence-based changes that create lasting results, not just temporary symptom suppression.
Yes, completely. PMOS (Polyendocrine Metabolic Ovarian Syndrome) is the updated, more accurate name for the condition previously called PCOS (Polycystic Ovary Syndrome). The condition itself, including its symptoms, diagnostic criteria, and underlying mechanisms, has not changed. Only the name has been updated, as of May 12, 2026, to better reflect the true hormonal and metabolic nature of the condition.
The word “cyst” in PCOS was clinically inaccurate, and the name as a whole failed to reflect the true nature of the condition. The rename to Polyendocrine Metabolic Ovarian Syndrome, published in The Lancet on May 12, 2026 by a global consortium and endorsed by the Endocrine Society, was driven by three goals: accuracy (the condition involves multiple endocrine glands and metabolic dysfunction, not just ovarian cysts), better diagnosis (by broadening clinical focus beyond the ovaries), and reducing stigma for the more than 170 million women affected worldwide.
Some will, and some will not yet. Medical terminology changes take time to filter through into everyday clinical practice. Your GP or gynaecologist may still use PCOS. Both terms refer to the same condition and if you come across both in your research, do not be alarmed.
From a root-cause perspective, we prefer the term “managed at the root cause” rather than reversed, because PMOS has a genetic component. However, the metabolic and hormonal drivers, including insulin resistance, inflammation, and cortisol dysregulation, are absolutely modifiable. Many women achieve regular cycles, improved fertility, and resolution of symptoms like acne and excess hair through targeted lifestyle, nutrition, and supplement protocols.
There is no single PMOS diet that works for everyone, but the core principles include reducing refined carbohydrates and sugar to address insulin resistance, eating adequate protein with every meal, including anti-inflammatory fats like omega-3s, prioritising fibre for gut health and oestrogen clearance, and avoiding seed oils and ultra-processed foods. A personalised approach based on your specific hormone panel and metabolic markers will always yield better results than a generic plan. Our 21-Day Hormone Reset is built on exactly these principles.
Start by tracking your symptoms and your cycle. If you experience irregular periods, unexplained weight gain, acne, excess facial hair, or difficulty conceiving, speak to your doctor about a hormone panel and pelvic ultrasound. You can also take our free hormone imbalance quiz to get an initial sense of where your hormones may be out of balance.